0,891  0,005  Antiinflammatory
0,843  0,004  Sensitization
0,846  0,011  Apoptosis agonist
0,772  0,004  Antineoplastic (pancreatic cancer)
0,768  0,005  Nitric oxide antagonist
0,747  0,014  Antineoplastic (breast cancer)
0,691  0,010  Chemopreventive
0,682  0,023  Transcription factor NF kappa B inhibitor
0,659  0,001  Ornithine decarboxylase inhibitor
0,656  0,007  AR expression inhibitor
0,674  0,027  Caspase 9 stimulant
0,614  0,008  Antineoplastic (glioma)
0,609  0,013  Antineoplastic (cervical cancer)
0,595  0,017  Antihypercholesterolemic
0,577  0,007  Antineoplastic (glioblastoma multiforme)
0,570  0,003  Abortion inducer
0,546  0,004  Contraceptive
0,548  0,014  CYP2C19 inhibitor
0,562  0,032  TNF expression inhibitor
0,529  0,009  Antineoplastic (endocrine cancer)
0,519  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,540  0,025  Prostate cancer treatment
0,542  0,030  Antibacterial
0,533  0,022  Bone diseases treatment
0,514  0,005  Antiacne
0,525  0,017  Antiosteoporotic
0,527  0,026  Immunosuppressant
0,528  0,032  Antineoplastic (colorectal cancer)
0,496  0,005  Protein-tyrosine phosphatase inhibitor
0,494  0,005  Prostate disorders treatment
0,519  0,033  CYP2C9 substrate
0,512  0,032  Antineoplastic (colon cancer)
0,512  0,043  Antineoplastic (lung cancer)
0,469  0,008  Prostatic (benign) hyperplasia treatment
0,490  0,036  Antipruritic, allergic
0,436  0,004  Contraceptive male
0,435  0,005  Antiviral (Influenza A)
0,445  0,024  ICAM1 expression inhibitor
0,448  0,031  Hepatic disorders treatment
0,442  0,029  Apoptosis antagonist
0,442  0,032  Antineoplastic (melanoma)
0,419  0,009  Antiviral (Influenza)
0,418  0,010  Interferon gamma antagonist
0,432  0,031  NOS3 expression inhibitor
0,414  0,016  UGT1A1 substrate
0,405  0,011  Hair growth stimulant
0,429  0,041  Teratogen
0,408  0,024  Cardiodepressant
0,411  0,028  UGT2B4 substrate
0,412  0,030  NOS2 expression inhibitor
0,425  0,045  Cholesterol antagonist
0,408  0,035  Cytotoxic
0,387  0,021  Sodium/bile acid cotransporter inhibitor
0,416  0,059  Antileukemic
0,370  0,019  UGT1A4 substrate
0,391  0,040  Antiepileptic
0,395  0,047  Antifungal
0,346  0,003  5-Alpha-reductase inhibitor
0,381  0,044  Spasmolytic
0,340  0,004  Potassium channel large-conductance Ca-activated activator
0,380  0,045  Embryotoxic
0,419  0,084  Antiarthritic
0,338  0,005  ABCA1 expression enhancer
0,382  0,049  5 Hydroxytryptamine release stimulant
0,375  0,044  Cardioprotectant
0,347  0,019  Hepatoprotectant
0,362  0,035  Antihypoxic
0,371  0,046  CYP2C19 substrate
0,340  0,015  Lipocortins synthesis antagonist
0,331  0,008  Cholesterol synthesis inhibitor
0,329  0,011  Interleukin 6 antagonist
0,350  0,038  Carcinogenic
0,353  0,045  Antioxidant
0,328  0,021  UGT2B7 substrate
0,359  0,055  Antineoplastic (ovarian cancer)
0,347  0,044  Antineoplastic (non-small cell lung cancer)
0,333  0,031  Antihypertriglyceridemic
0,357  0,054  Antipsoriatic
0,395  0,094  Cyclophilin D inhibitor
0,395  0,094  Antidiabetic
0,328  0,027  Growth hormone agonist
0,339  0,047  Chemoprotective
0,326  0,041  Antineoplastic (liver cancer)
0,323  0,038  UGT1A6 substrate
0,301  0,022  Diuretic
0,305  0,030  Gastrin inhibitor
0,284  0,011  Endometrios treatment
0,331  0,062  Respiratory analeptic
0,361  0,095  Histamine release inhibitor
0,287  0,024  Antipruritic, non-allergic
0,267  0,012  Antineoplastic antibiotic
0,291  0,037  UDP-glucuronosyltransferase substrate
0,304  0,050  Cardiovascular analeptic
0,258  0,005  Postmenopausal disorders treatment
0,315  0,063  Lipoprotein disorders treatment
0,334  0,084  CYP3A4 substrate
0,261  0,017  UGT2B9 substrate
0,318  0,075  Calcium channel activator
0,308  0,075  Caspase 3 stimulant
0,241  0,009  Contraceptive female
0,235  0,005  Adenylate cyclase stimulant
0,269  0,045  Antiviral (HIV)
0,297  0,077  Analeptic
0,252  0,032  Antiviral (Hepatitis)
0,242  0,023  Cyclooxygenase 1 inhibitor
0,250  0,032  Antiviral (Herpes)
0,231  0,019  UGT2B10 substrate
0,260  0,051  Mutagenic
0,236  0,031  UGT2B15 substrate
0,267  0,065  Proliferative diseases treatment
0,285  0,083  Antineoplastic (osteosarcoma)
0,229  0,030  Phospholipase C inhibitor
0,260  0,063  Hypolipemic
0,208  0,014  Growth stimulant
0,263  0,069  Hypoglycemic
0,223  0,031  Antiviral (Hepatitis C)
0,216  0,029  Antidiarrheal
0,191  0,005  Anabolic
0,210  0,024  Arachidonic acid antagonist
0,221  0,043  Thrombolytic
0,256  0,078  Transcription factor STAT3 inhibitor
0,221  0,047  Muscle relaxant
0,216  0,043  UGT1A3 substrate
0,191  0,019  Choleretic
0,247  0,076  Tumour necrosis factor alpha release inhibitor
0,292  0,122  CYP2C9 inhibitor
0,247  0,078  Vascular (periferal) disease treatment
0,241  0,073  DNA synthesis inhibitor
0,276  0,110  Vasodilator, peripheral
0,239  0,075  Angiogenesis stimulant
0,232  0,069  Antiparasitic
0,220  0,058  Antihelmintic
0,218  0,058  Non-steroidal antiinflammatory agent
0,163  0,005  Aldosterone antagonist
0,172  0,017  Androgen antagonist
0,148  0,004  Liver X receptor alpha agonist
0,154  0,015  Inducible nitric-oxide synthase inhibitor
0,171  0,032  Cyclooxygenase 3 inhibitor
0,153  0,014  UGT2B11 substrate
0,162  0,024  HDL-cholesterol increasing
0,205  0,071  Neurotrophic factor enhancer
0,140  0,008  Na+ K+ transporting ATPase inhibitor
0,223  0,092  Antipyretic
0,186  0,057  Antirickettsial
0,178  0,049  Insulin secretagoues
0,144  0,017  Transcription factor NF kappa B stimulant
0,190  0,064  LDLR expression enhancer
0,163  0,037  Adenylate cyclase inhibitor
0,151  0,026  Antiinfertility, female
0,128  0,004  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,160  0,039  Antihemorrhagic
0,205  0,083  Antiparkinsonian, rigidity relieving
0,160  0,041  Antiviral (Hepatitis B)
0,122  0,004  Heme oxygenase stimulant
0,236  0,120  Antimycobacterial
0,166  0,054  Anesthetic
0,117  0,004  Postcoital contraceptive
0,165  0,054  Skeletal muscle relaxant
0,219  0,109  Immunostimulant
0,179  0,069  Succinate dehydrogenase inhibitor
0,128  0,019  Keratolytic
0,122  0,014  Estrogen agonist
0,201  0,093  Cyclic AMP phosphodiesterase inhibitor
0,124  0,022  Phosphodiesterase 6D inhibitor
0,187  0,088  Pneumotoxic
0,224  0,125  Hypoxia-inducible factor 1 alpha inhibitor
0,136  0,044  Alcohol dehydrogenase substrate
0,130  0,038  Estrogen antagonist
0,178  0,088  Anesthetic general
0,095  0,005  Retinoid X receptor agonist
0,160  0,071  Antimutagenic
0,129  0,041  UGT2B1 substrate
0,137  0,049  CC chemokine 6 receptor antagonist
0,156  0,070  Acute respiratory distress syndrome (ARDS) treatment
0,090  0,004  Parathyroid hormone antagonist
0,152  0,067  Protein kinase stimulant
0,088  0,005  Adenylate cyclase 1 inhibitor
0,097  0,016  Androgen agonist
0,121  0,040  Antiviral (SARS coronavirus)
0,121  0,040  Antiviral (Coronavirus)
0,085  0,004  Retinoid X gamma receptor agonist
0,087  0,006  Retinoid X alpha receptor agonist
0,142  0,062  Farnesoid X receptor antagonist
0,117  0,038  Antihypermotility
0,157  0,079  Antihelmintic (Nematodes)
0,130  0,051  Microtubule formation inhibitor
0,086  0,009  Liver X receptor agonist
0,126  0,050  Ferrochelatase inhibitor
0,112  0,037  Actinic keratosis treatment
0,101  0,027  CDC25A inhibitor
0,107  0,036  Bile acid receptor antagonist
0,145  0,074  Cyclooxygenase inhibitor
0,088  0,018  Antimycoplasmal
0,150  0,083  Urinary incontinence treatment
0,115  0,048  Sulfotransferase substrate
0,070  0,004  Retinoid X beta receptor agonist
0,148  0,084  Melanin inhibitor
0,170  0,107  Insulin sensitizer
0,200  0,138  Transcription factor STAT inhibitor
0,095  0,037  Glycine receptor antagonist
0,065  0,008  Retinoic acid alpha receptor agonist
0,127  0,070  Antihyperlipoproteinemic
0,118  0,061  TRPA1 agonist
0,137  0,082  Pregnane X receptor agonist
0,077  0,023  Andropause treatment
0,060  0,007  5-Alpha-reductase 2 inhibitor
0,104  0,052  Potassium channel (Ca-activated) activator
0,201  0,149  5 Hydroxytryptamine uptake stimulant
0,063  0,011  RNA-directed RNA polymerase stimulant
0,197  0,145  CYP2D6 substrate
0,061  0,009  Hypogonadism treatment
0,096  0,045  Antispirochetal
0,166  0,115  Antiulcerative
0,069  0,018  Acetyl-CoA transferase 2 inhibitor
0,171  0,121  Antiprotozoal (Leishmania)
0,066  0,016  Mineralocorticoid receptor antagonist
0,080  0,032  Anticholelithogenic
0,069  0,023  Lipocortins synthesis agonist
0,055  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,054  0,009  Retinoid X receptor antagonist
0,075  0,033  SULT2A1 substrate
0,102  0,060  Estrogen receptor beta antagonist
0,080  0,039  Glycine receptor agonist
0,096  0,055  SULT1E1 substrate
0,063  0,022  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,054  0,013  Farnesoid X receptor agonist
0,047  0,008  Retinoid X alpha receptor antagonist
0,107  0,069  SULT1A1 substrate
0,042  0,004  Retinoic acid receptor antagonist
0,187  0,149  UGT1A9 substrate
0,051  0,015  GABA uptake inhibitor
0,044  0,008  HCV polyprotein inhibitor
0,041  0,005  Progesterone agonist
0,040  0,005  Retinoid X gamma receptor antagonist
0,047  0,012  Liver X receptor beta agonist
0,206  0,170  Antithrombotic
0,042  0,008  5-Alpha-reductase 1 inhibitor
0,102  0,067  Expectorant
0,041  0,006  Retinoic acid receptor agonist
0,037  0,004  Retinoic acid gamma receptor agonist
0,055  0,022  Estradiol 17 beta-dehydrogenase inhibitor
0,035  0,004  Retinoid X beta receptor antagonist
0,057  0,026  Anesthetic inhalation
0,042  0,012  Cholesterol ester transfer protein antagonist
0,036  0,007  Nicotinic acid receptor 2 antagonist
0,033  0,005  Retinoic acid alpha receptor antagonist
0,032  0,005  Retinoic acid beta receptor agonist
0,093  0,069  Electrolyte absorption antagonist
0,042  0,019  Glucose-6-phosphate dehydrogenase inhibitor
0,040  0,019  Glucocorticoid antagonist
0,088  0,067  Glutamate release inhibitor
0,034  0,014  Liver X receptor alpha antagonist
0,076  0,056  Estrogen receptor alpha antagonist
0,216  0,197  Antineoplastic (non-Hodgkin's lymphoma)
0,114  0,097  Antifungal enhancer
0,079  0,063  Antiprotozoal activity enhancer
0,071  0,055  Antibiotic
0,061  0,046  Nitric oxide donor
0,034  0,019  ATP citrate lysase inhibitor
0,121  0,108  Genotoxic
0,057  0,044  Prostaglandin EP2 antagonist
0,204  0,192  FMO1 substrate
0,017  0,005  Retinoic acid beta receptor antagonist
0,016  0,005  Retinoic acid receptor gamma antagonist
0,089  0,078  Glutathione S-transferase substrate
0,060  0,050  CDC25B inhibitor
0,022  0,013  Corticosteroid-like
0,101  0,092  Menstruation disorders treatment
0,082  0,073  Potassium channel activator
0,022  0,014  Vitamin D receptor antagonist
0,190  0,182  Antihypertensive
0,055  0,047  Biliverdin reductase inhibitor
0,030  0,023  Liver X receptor antagonist
0,033  0,027  Progesterone antagonist
0,058  0,053  Hyperparathyroidism treatment
0,016  0,012  Vitamin D receptor agonist
0,109  0,106  Skin whitener
0,095  0,093  Carcinogenic, group 3
0,118  0,117  Sigma receptor agonist
0,043  0,043  Prostaglandin E2 antagonist
0,048  0,047  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,112  0,112  Psychosexual dysfunction treatment

